These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34243681)

  • 81. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation.
    Afrin R; Arumugam S; Rahman A; Wahed MI; Karuppagounder V; Harima M; Suzuki H; Miyashita S; Suzuki K; Yoneyama H; Ueno K; Watanabe K
    Int Immunopharmacol; 2017 Mar; 44():174-182. PubMed ID: 28110063
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
    Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.
    Chen Z; Liu F; Zheng N; Guo M; Bao L; Zhan Y; Zhang M; Zhao Y; Guo W; Ding G
    Biomed Pharmacother; 2019 Feb; 110():285-293. PubMed ID: 30522014
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway.
    Li C; Zhou W; Li M; Shu X; Zhang L; Ji G
    Biomed Pharmacother; 2021 Jul; 139():111587. PubMed ID: 33865013
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
    Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
    Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
    Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
    J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis.
    Huang C; Liu Q; Tang Q; Jing X; Wu T; Zhang J; Zhang G; Zhou J; Zhang Z; Zhao Y; Huang H; Xia Y; Yan J; Xiao J; Li Y; He J
    Free Radic Biol Med; 2021 Jun; 169():110-121. PubMed ID: 33857628
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pterostilbene alleviates polymicrobial sepsis-induced liver injury: Possible role of SIRT1 signaling.
    Liu X; Yang X; Han L; Ye F; Liu M; Fan W; Zhang K; Kong Y; Zhang J; Shi L; Chen Y; Zhang X; Lin S
    Int Immunopharmacol; 2017 Aug; 49():50-59. PubMed ID: 28550734
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice.
    Luo Y; Dong X; Yu Y; Sun G; Sun X
    J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S; Wang J; Liu Q; Harnish DC
    J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1.
    Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Fang M; Xia J; Xu Y
    Oncotarget; 2016 Jul; 7(28):42892-42903. PubMed ID: 27285989
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
    Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis.
    Zhang J; Jiang D; Lin S; Cheng Y; Pan J; Ding W; Chen Y; Fan J
    Life Sci; 2021 Apr; 270():119131. PubMed ID: 33516698
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
    Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
    BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Silibinin Ameliorates
    Lee SJ; Nam MJ; Lee DE; Park JW; Kang BS; Lee DS; Lee HS; Kwon OS
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042374
    [TBL] [Abstract][Full Text] [Related]  

  • 98. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
    Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
    J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    Bae CR; Zhang H; Kwon YG
    PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.